MedPath

福州海王福药制药有限公司

Ownership
-
Established
2001-06-07
Employees
-
Market Cap
-
Website
www.fzhwfy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

283

NMPA:283

Drug Approvals

Atropine Sulfate Injection

Product Name
硫酸阿托品注射液
Approval Number
国药准字H20247198
Approval Date
Aug 23, 2024
NMPA

Sildenafil Citrate Orodispersible Tablets

Product Name
枸橼酸西地那非口崩片
Approval Number
国药准字H20244332
Approval Date
Jun 28, 2024
NMPA

Homoharringtonine Injection

Product Name
高三尖杉酯碱注射液
Approval Number
国药准字H35020457
Approval Date
Jun 26, 2024
NMPA

Progesterone Injection

Product Name
黄体酮注射液
Approval Number
国药准字H35020175
Approval Date
Jun 26, 2024
NMPA

Aciclovir and Glucose Injection

Product Name
阿昔洛韦葡萄糖注射液
Approval Number
国药准字H20050089
Approval Date
Jun 26, 2024
NMPA

Methionine and Vitamin B₁ Injection

Product Name
甲硫氨酸维 b₁注射液
Approval Number
国药准字H20056648
Approval Date
Jun 26, 2024
NMPA

Nefopam Hydrochloride Injection

Product Name
盐酸奈福泮注射液
Approval Number
国药准字H20044200
Approval Date
Jun 26, 2024
NMPA

Actinomycin

Product Name
新福菌素
Approval Number
国药准字H35021179
Approval Date
Jan 16, 2024
NMPA

Tegafur, Gimeracil and Oteracil Potassium Tablets

Product Name
替吉奥片
Approval Number
国药准字H20140019
Approval Date
Dec 7, 2023
NMPA

Tegafur, Gimeracil and Oteracil Potassium Tablets

Product Name
替吉奥片
Approval Number
国药准字H20140020
Approval Date
Dec 7, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 29
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.